By competing with CD47, it inhibits CD47-induced macrophage phagocytosis and enhances antibody-dependent phagocytosis of macrophages to eliminate tumor cells (Figure 7) (Kim et al., 2008). The gene discussed is CD47; the disease is neoplasm.